Treatment of intrahepatic cholestatic diseases
US11596614B2 · kind B2 · utility
0Cited by
19References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2021 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | Oct 29, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.